Anavex Life Sciences forges ahead with promising Parkinson’s Disease Treatment
Anavex Life Sciences, a renowned name in the field of pharmaceuticals, is making
significant strides towards treating Parkinson's disease. The company’s
investigational agent, blarcamesine, is deemed safe and efficient after its
recent Phase 2 extension study.
The company is committed to developing targeted therapeutic treatments for patients with
neurodegenerative and neurodevelopmental disorders including Alzheimer's
disease,...